Barrow Hanley Mewhinney & Strauss LLC Merck & Co., Inc. Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $28.9 Billion
- Q3 2024
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 5,656,602 shares of MRK stock, worth $556 Million. This represents 2.22% of its overall portfolio holdings.
Number of Shares
5,656,602
Previous 5,891,756
3.99%
Holding current value
$556 Million
Previous $729 Million
11.93%
% of portfolio
2.22%
Previous 2.63%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,814Shares Held
1.88BCall Options Held
14.6MPut Options Held
13.2M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.46 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.82 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...